Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in...
Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer
About this item
Full title
Author / Creator
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
The association of tyrosine kinase inhibitors (TKIs) and local radiotherapy in
-mutated non-small-cell lung cancer patients experiencing disease progression under TKIs could be a valid an option.
We included 131 patients experiencing disease progression during first-line TKI. In group A, patients received TKI beyond progression and site(s) of...
Alternative Titles
Full title
Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2313665070
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2313665070
Other Identifiers
ISSN
1479-6694
E-ISSN
1744-8301
DOI
10.2217/fon-2019-0349
